Page 205 - Read Online
P. 205

Page 10 of 12                                                  Tagliari et al. Vessel Plus 2020;4:16  I  http://dx.doi.org/10.20517/2574-1209.2020.05
               Availability of data and materials
               Not applicable.


               Financial support and sponsorship
               Dr. Tagliari’s scientific research is supported by Coordenação de Aperfeiçoamento de Pessoal de Nível
               Superior - Brasil (Capes) - Finance Code 001.

               Conflicts of interest
               Dr. Taramasso is a consultant for Abbott Vascular, Boston Scientific, 4TECH, and CoreMedic; and has
               received speaker honoraria from Edwards Lifesciences.

               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2020.

               REFERENCES
               1.   Leon MB, Smith CR, Mack MJ, Miller DC, Moses JW, et al. Transcatheter aortic-valve implantation in patients who cannot undergo
                   surgery. N Engl J Med 2010;363:1597-607.
               2.   Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients.
                   N Engl J Med 2011;364:2187-98.
               3.   Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, et al. Registry of transcatheter aortic-valve implantation in high-risk
                   patients. N Engl J Med 2012;366:1705-15.
               4.   Paradis JM, Fried J, Nazif T, Kirtane A, Harjai K, et al. Aortic stenosis and coronary artery disease: what do we know? What don’t we
                   know? A comprehensive review of the literature with proposed treatment algorithms. Eur Heart J 2014;35:2069-82.
               5.   Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, et al. Transcatheter aortic-valve replacement with a self-expanding
                   prosthesis. N Engl J Med 2014;370:1790-8.
               6.   Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk
                   patients. N Engl J Med 2016;374:1609-20.
               7.   Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, et al. Surgical or transcatheter aortic-valve replacement in
                   intermediate risk patients. N Engl J Med 2017;376:1321-31.
               8.   Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve
                   in low-risk patients. N Engl J Med 2019;380:1695-705.
               9.   Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-
                   risk patients. N Engl J Med 2019;380:1706-15.
               10.  Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, et al. ESC/EACTS Guidelines for the management of valvular heart disease: the
                   task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for
                   Cardio-Thoracic Surgery (EACTS). Eur Heart J 2017;38:2739-91.
               11.  Yang Y, Huang FY, Huang BT, Xiong TY, Pu XB, et al. The safety of concomitant transcatheter aortic valve replacement and
                   percutaneous coronary intervention: a systematic review and meta-analysis. Medicine (Baltimore) 2017;96:e8919.
               12.  Penkalla A, Pasic M, Drews T, Buz S, Dreysse S, et al. Transcatheter aortic valve implantation combined with elective coronary artery
                   stenting: a simultaneous approach. Eur J Cardiothorac Surg 2015;47:1083-9.
               13.  Li J, Patel SM, Nadeem F, Thakker P, Al-Kindi S, et al. Impact of residual coronary atherosclerosis on transfemoral transcatheter aortic
                   valve replacement. Catheter Cardiovasc Interv 2019;93:545-52.
               14.  Blumenstein J, Kim W, Liebetrau C, Gaede L, Kempfert J, et al. Challenges of coronary angiography and intervention in patients
                   previously treated by TAVI. Clin Res Cardiol 2015;104:632-9.
               15.  Tang GHL, Zaid S, Gupta E, Ahmad H, Patel N, et al. Impact of initial evolut transcatheter aortic valve replacement deployment
                   orientation on final valve orientation and coronary reaccess. Circ Cardiovasc Interv 2019;12:e008044.
               16.  Ochiai T, Yoon SH, Flint N, Sharma R, Patel V, et al. TCT-683 variation in the timing of percutaneous coronary intervention and
                   outcomes in patients undergoing transcatheter aortic valve replacement. J Am Coll Cardiol 2019;74:B670.
               17.  Hutter A, Bleiziffer S, Richter V, Opitz A, Hettich I, et al. Transcatheter aortic valve implantation in patients with concomitant mitral and
   200   201   202   203   204   205   206   207   208   209   210